Altimmune (NASDAQ: ALT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.
The latest price target for Altimmune (NASDAQ: ALT) was reported by HC Wainwright & Co. on Wednesday, August 17, 2022. The analyst firm set a price target for 50.00 expecting ALT to rise to within 12 months (a possible 185.71% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Altimmune (NASDAQ: ALT) is $17.5 last updated Today at August 17, 2022, 6:36 PM UTC.
There are no upcoming dividends for Altimmune.
Altimmune’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.